These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13915501)

  • 1. [Effect of oxolamine on respiratory function, carbonic anhydrase and prothrombin level in pulmonary tuberculosis].
    SOZIO N; MARTELLOTTA G; PELLEGRINOV ; ABBAMONTE P
    Minerva Med; 1961 Oct; 52():3760-3. PubMed ID: 13915501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carbonic anhydrase quantity of tuberculous subjects (author's transl)].
    Yoshioka N; Shimizu K; Oshima T; Kimura T
    Rinsho Byori; 1976 Jul; 24(7):585-8. PubMed ID: 823351
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of and action on prothrombin time during drug treatment of pulmonary tuberculosis].
    HAIZMANN R; KELLER N
    Dtsch Med J; 1953 Apr; 4(7-8):159-61. PubMed ID: 13068169
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of the use of a new cough preparation in pulmonary tuberculosis].
    GIULIANO V; ROSSA G
    Minerva Med; 1955 Nov; 46(94):1502-4. PubMed ID: 13288055
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of tuberculostatic treatment of pulmonary tuberculosis on the prothrombin complex with special reference to neoteben].
    RICHTER WC
    Tuberkulosearzt; 1953 Oct; 7(10):592-7. PubMed ID: 13136491
    [No Abstract]   [Full Text] [Related]  

  • 6. [1st experiences with the antitussive Germapect in the treatment of pulmonary tuberculosis].
    LANGE-GIESEMANN E
    Hippokrates; 1962 Mar; 33():220-4. PubMed ID: 14462085
    [No Abstract]   [Full Text] [Related]  

  • 7. [PATHOGENIC MEDICATION IN PNEUMO-PHTHISIOLOGY: OXOLAMINE CITRATE, A RESPIRATORY TRACT ANTI-INFLAMMATORY AGENT. STUDY OF A FEW INDICATIONS, ESPECIALLY IN PULMONARY TUBERCULOTICS].
    TESSIER R; QUINTON A; DOUTRES JC
    J Med Bord; 1965 Mar; 142():463-9. PubMed ID: 14310316
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of carbonic anhydrase activity in blood by alteration in pH.
    Tripathi K; Upadhyay L
    Indian J Exp Biol; 1998 Sep; 36(9):940-2. PubMed ID: 9854436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [OXOLAMINE ALONE AND COMBINED WITH TETRACYCLINE IN THE TREATMENT OF CHRONIC DISORDERS OF THE RESPIRATORY TRACT].
    MULARGIA A
    Policlinico Med; 1964 Jun; 71():204-16. PubMed ID: 14182020
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with oxolamine (Perebron)].
    UMEHARA S; UEKI M; ITO H; ISHII A; TABAYASHI T; KOSHIISHI Y; MUKAI T
    Minerva Med; 1961 Oct; 52():3741-5. PubMed ID: 13923758
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of Oxolamine].
    SILVESTRINI B
    Boll Chim Farm; 1961 Nov; 100():869-72. PubMed ID: 13912974
    [No Abstract]   [Full Text] [Related]  

  • 12. [The recent introduction in therapy of a new antitussive drug: oxolamine].
    ROTTINI E; MARRI G; CALANDRA P
    Minerva Med; 1961 Oct; 52():3758-60. PubMed ID: 14494482
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical contribution to the study of the therapeutic activity of oxolamine citrate].
    ELEFANTE E
    Gazz Med Ital; 1962 Jun; 121():160-3. PubMed ID: 13889804
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the use of oxolamine citrate in bronchitic recurrences].
    TROPIA G
    Minerva Med; 1961 Oct; 52():3750-2. PubMed ID: 13922605
    [No Abstract]   [Full Text] [Related]  

  • 15. [The therapeutic action of oxolamine in chronic bronchitis].
    MELIS A
    Minerva Med; 1961 Oct; 52():3756-8. PubMed ID: 14472372
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the use of oxolamine in bronchospastic syndromes. Clinical observations].
    LANGER M
    Minerva Med; 1961 Oct; 52():3747-50. PubMed ID: 14462120
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the anti-inflammatory action of oxolamine citrate].
    GIUDICI G; LEGNANI F
    Minerva Med; 1961 Oct; 52():3752-5. PubMed ID: 13898986
    [No Abstract]   [Full Text] [Related]  

  • 18. [PROTHROMBIN (QUICK) TIME AND PLASMA FIBRINOGEN IN SUBJECTS AFFECTED BY PULMONARY TUBERCULOSIS TREATED BY CORTICOTHERAPY AND CHEMOANTIBIOTIC THERAPY].
    DESIMONI G; FRISANI G; DEMARINIS A
    Lotta Tuberc; 1964 Dec; 34():1047-51. PubMed ID: 14311893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of p-aminosalicylic acid on the prothrombin and thromboplastin level in pulmonary tuberculosis].
    MARRA A
    Arch Tisiol Mal Appar Respir; 1950 Apr; 5(4):341-4. PubMed ID: 14777683
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood carbonic anhydrase activity in anesthetized man.
    CHRISTIAN G; GREENE NM
    Anesthesiology; 1962; 23():179-86. PubMed ID: 13879280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.